Yeah, people have a variety of opinions about Compass.
Compass and the Usona Institute are independently pursuing FDA rescheduling of psilocybin. Compass is likely to have their product rescheduled first.
I think it’s good that Usona is working through the FDA process, because they’re a nonprofit and thus have a different incentive-set than Compass.
Just saw that Good Ventures continues to support Usona’s research (separate from their involvement with Open Phil).
Interesting, thanks.
Yeah, people have a variety of opinions about Compass.
Compass and the Usona Institute are independently pursuing FDA rescheduling of psilocybin. Compass is likely to have their product rescheduled first.
I think it’s good that Usona is working through the FDA process, because they’re a nonprofit and thus have a different incentive-set than Compass.
Just saw that Good Ventures continues to support Usona’s research (separate from their involvement with Open Phil).
Interesting, thanks.